The Society’s journals have all increased their standing in the new impact factors announced in June. The impact factors, produced by Philadelphia-based company Thomson Reuters (formerly ISI), reflect the average number of citations in 2008 of articles published in 2006 and 2007.

Journal of Endocrinology’s previous figure had been depressed by the huge increase in material published in 2006 (compared with the previous year). The new figure signals its recovery is well underway with a climb of over 0.15 to 2.791. Thomson Reuters' latest report also announces, for the first time, the journal’s 'five-year impact factor', which at 3.184, demonstrates JOE’s continued underlying strength.

Journal of Molecular Endocrinology is back decisively above the psychologically important 3.0 mark at 3.225. Given Anna Spada and Jacky Burrin’s energetic new editorial initiatives, JME looks set to strengthen further in the years to come.

Endocrine-Related Cancer has consolidated its consistently excellent position with a further increase to 5.236, demonstrating its status as the established global forum for high-quality research on hormones and cancer.

Clinical Endocrinology continues to demonstrate its profile and standing with a new score of 3.398, an increase on its already strong figure last year. In addition, the new 'five-year' figure stands at an impressive 3.791.

The Society’s journals are all accessible via the link below.

Society journals